Showing results (121-130 of 137) with videos related to
Sort By:
Pageof 14
Molecular Pharmacology|March 1, 1994
Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cellsY Y Yang, E S Woo, C E Reese, et al.Toxicology and Applied Pharmacology|March 1, 1994
Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserumS M Kuo, Y Kondo, J M DeFilippo, et al.The Prostate|July 27, 1999
Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostatesP H Gann, K G Klein, R T Chatterton, et al.The Journal of Urology|June 1, 1984
Adjuvant doxorubicin hydrochloride and radiation in stage D bladder cancer: a preliminary reportA J Schaeffer, J T Grayhack, J M Merrill, et al.Archives of Pathology & Laboratory Medicine|August 3, 2000
Carcinosarcoma of the urinary bladder--an aggressive tumor with diverse histogenesis. A clinicopathologic study of 4 cases and review of the literatureD Y Baschinsky, J H Chen, M S Vadmal, et al.The Journal of Urology|July 1, 1995
Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer: an Eastern Cooperative Oncology Group studyD B Glazier, R R Bahnson, D G McLeod, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysisD L Trump, D C Smith, D Stiff, et al.Journal of Andrology|July 1, 1993
Effect of spermatocele fluid on growth of human prostatic cells in cultureD M Sutkowski, R Z Kasjanski, J A Sensibar, et al.Cancer Research|April 1, 1996
Bladder cancer-associated nuclear matrix proteinsR H Getzenberg, B R Konety, T A Oeler, et al.Urology|February 1, 1992
Interferon-induced reversible acute renal failure with nephrotic syndromeS Nair, M S Ernstoff, R R Bahnson, et al.Pageof 14